Literature DB >> 35104905

Quantitative Proteomics Based on iTRAQ Reveal that Nitidine Chloride Induces Apoptosis by Activating JNK/c-Jun Signaling in Hepatocellular Carcinoma Cells.

Shipeng Chen1,2, Yinan Liao1, Jinyan Lv1, Huaxin Hou1, Jie Feng1.   

Abstract

The aim of the present study was to investigate the cytotoxic effects and underlying molecular mechanisms of nitidine chloride (NC) in hepatocellular carcinoma cells via quantitative proteomics. MTT assays were used to detect the inhibitory effects of NC in Bel-7402 liver cancer cells, and the number of apoptotic cells was measured by flow cytometry. Quantitative proteomics technology based on iTRAQ was used to discover differential expressed proteins after NC treatment, and bioinformatic techniques were further used to screen potential targets of NC. Molecular docking was applied to evaluate the docking activity of NC with possible upstream proteins, and their expression was detected at the mRNA and protein levels by quantitative reverse transcription PCR and western blotting. NC inhibited the proliferation of Bel-7402 cells after 24 h of treatment and stimulated apoptosis in vitro. The proteomics experiment showed that NC triggers mitochondrial damage in HCC cells and transcription factor AP-1 (c-Jun) may be a potential target of NC (fold change = 4.36 ± 0.23). Molecular docking results revealed the highest docking score of NC with c-Jun N-terminal kinase (JNK), one of the upstream proteins of c-Jun. Moreover, the mRNA and protein expression of c-Jun and JNK were significantly increased after NC treatment (p < 0.05). These findings indicate that NC significantly induced mitochondrial damage in HCC cells, and induced apoptosis by activating JNK/c-Jun signaling. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35104905     DOI: 10.1055/a-1676-4307

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.007


  1 in total

1.  Nitidine chloride induces caspase 3/GSDME-dependent pyroptosis by inhibting PI3K/Akt pathway in lung cancer.

Authors:  Fei Yu; Weidan Tan; Zhiquan Chen; Xiaoju Shen; Xiaoxiang Mo; Xiaocheng Mo; Jingchuan He; Zhihua Deng; Jie Wang; Zhuo Luo; Jie Yang
Journal:  Chin Med       Date:  2022-09-29       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.